Valeant Pharmaceuticals is a global pharmaceutical company known for developing and marketing a wide range of medications, particularly in the fields of dermatology, ophthalmology, and neurology. Founded in 1960, the company has grown through a series of acquisitions, expanding its product portfolio and market reach. In recent years, Valeant has faced scrutiny over its pricing practices and business strategies, leading to significant changes in leadership and corporate structure. The company has since rebranded itself as Bausch Health Companies to reflect its commitment to transparency and patient care while continuing to focus on innovative healthcare solutions.